苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688513 苑东生物

交易中 08-01 13:48:23

{"stockData":{"symbol":"688513","market":"SH","secType":"STK","nameCN":"苑东生物","latestPrice":61.41,"timestamp":1754027303000,"preClose":64.3,"halted":0,"volume":3623172,"delay":0,"changeRate":-0.0449,"floatShares":177000000,"shares":177000000,"eps":1.2679,"marketStatus":"交易中","change":-2.89,"latestTime":"08-01 13:48:23","open":63,"high":67.3,"low":61.07,"amount":230000000,"amplitude":0.0969,"askPrice":62.19,"askSize":5,"bidPrice":61.45,"bidSize":14,"shortable":0,"etf":0,"ttmEps":1.2679,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1754031600000},"marketStatusCode":2,"adr":0,"adjPreClose":64.3,"symbolType":"stock_kcb","openAndCloseTimeList":[[1754011800000,1754019000000],[1754024400000,1754031600000]],"highLimit":70.73,"lowLimit":57.87,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":176532256,"isCdr":false,"pbRate":4.11,"roa":"--","peRate":48.434419,"roe":"2.22%","epsLYR":1.36,"committee":-0.291667,"marketValue":10841000000,"turnoverRate":0.0205,"status":1,"floatMarketCap":10841000000},"requestUrl":"/m/hq/s/688513","defaultTab":"news","newsList":[{"id":"2555469008","title":"苑东生物涨5.57% 创新药布局与政策预期提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2555469008","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555469008?lang=zh_cn&edition=full","pubTime":"2025-07-31 13:19","pubTimestamp":1753939167,"startTime":"0","endTime":"0","summary":"苑东生物股价大幅上涨，最新价66.00元/股，涨跌幅为5.57%。资金博弈与政策预期共振引发波动苑东生物近期的净流入主要受多重短期因素交织影响。截至7月30日，主力资金累计净流入呈现剧烈波动，7月25日单日净流入7586.9万元后，次日骤降至140万元，反映市场情绪快速切换。2025年一季度归母净利润同比下滑19.2%，核心品种集采降价叠加股权激励费用计提，加剧了短期业绩兑现压力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731131933a6cae366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731131933a6cae366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","688513","BK0239"],"gpt_icon":0},{"id":"2555016539","title":"7月30日苑东生物跌5.16%，博时研究优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555016539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555016539?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:13","pubTimestamp":1753863201,"startTime":"0","endTime":"0","summary":"证券之星消息，7月30日苑东生物跌5.16%，收盘报62.52元，换手率4.35%，成交量7.68万手，成交额4.88亿元。重仓苑东生物的前十大公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级1家，增持评级3家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为博时基金的博时研究优选LOF。博时研究优选LOF目前规模为8.62亿元，最新净值0.9012，较上一交易日上涨2.29%，近一年上涨42.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000025224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["160916","BK0239","688513"],"gpt_icon":0},{"id":"2555081024","title":"历史新高！中际旭创股价突破200元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555081024","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555081024?lang=zh_cn&edition=full","pubTime":"2025-07-29 12:40","pubTimestamp":1753764056,"startTime":"0","endTime":"0","summary":"CRO、创新药板块联手大涨，苑东生物、益方生物等个股盘中股价创历史新高。截至上午收盘，上证指数下跌0.08%，深证成指下跌0.04%，创业板指上涨0.92%。药明康德2025年中报显示，公司上半年营业收入、净利润均创下历史新高。其中，公司营业收入同比增长20.64%至207.99亿元；实现净利润85.61亿元，同比增长101.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072912410897249501&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072912410897249501&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603200","603229","688382","688513","601138","01093","688660","BK1161","603259","600276","688313","688630","BK1574","06978","02359","01276"],"gpt_icon":1},{"id":"2555089783","title":"苑东生物：实控人王颖及其一致行动人持股比例降至40.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089783","media":"21世纪经济报道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089783?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:45","pubTimestamp":1753760700,"startTime":"0","endTime":"0","summary":"此次减持共计336.9550万股，占公司总股本的1.91%，减持价格为每股42.06元。减持主体为苑东生物的员工持股平台，这些平台由公司控股股东、实际控制人、董事长王颖控制，但王颖本人并未参与此次减持。减持完成后，王颖及其一致行动人的持股比例从42.52%降至40.61%，变动比例触及1%的整数倍。减持的主要原因是转让方基于自身资金需求。受让方包括多家基金管理公司、私募基金管理人及证券公司，共10家机构投资者参与了此次询价转让，限售期为6个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729114532a468d184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729114532a468d184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688513","BK0239"],"gpt_icon":0},{"id":"2555070085","title":"医药板块震荡走强 多只个股涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2555070085","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555070085?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:35","pubTimestamp":1753756506,"startTime":"0","endTime":"0","summary":"人民财讯7月29日电，医药板块震荡走强，药石科技涨逾15%，亚太药业、辰欣药业、众生药业、罗欣药业等多只个股涨停，海特生物、苑东生物等大涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072910350694c0818a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072910350694c0818a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688513","159938","603367"],"gpt_icon":0},{"id":"2555085642","title":"单抗概念盘中拉升，苑东生物涨7.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555085642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555085642?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:14","pubTimestamp":1753755299,"startTime":"0","endTime":"0","summary":"07月29日，单抗概念盘中拉升，截至10点14分，单抗概念整体指数上涨1.10%，报2719.470点。从个股上来看，该概念的成分股中，苑东生物涨7.44%，迈威生物-U涨幅超过5%。从资金上来看，截止发稿，单抗概念概念主力净流入为-2.61亿，其中神州细胞受到资金热捧，主力净流入3545.89万；拉长时间线来看，该板块近20日主力资金净流入-5.13亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729101459a6c6dea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729101459a6c6dea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688520","688062","688513"],"gpt_icon":0},{"id":"2555408083","title":"创新药概念持续活跃 辰欣药业再度涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2555408083","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555408083?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:58","pubTimestamp":1753754333,"startTime":"0","endTime":"0","summary":"人民财讯7月29日电，创新药概念持续活跃，辰欣药业再度涨停，众生药业也涨停，苑东生物、亚太药业、三元基因等涨幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095853a468a105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095853a468a105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","688513","603367","BK0239"],"gpt_icon":0},{"id":"2555083401","title":"苑东生物涨5.06%创历史新高 创新药布局与政策红利共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2555083401","media":"智选洞察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555083401?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:51","pubTimestamp":1753753887,"startTime":"0","endTime":"0","summary":"苑东生物股价今日大幅上涨，截至09点50分，最新价报59.99元，涨幅达5.06%，创历史新高。资金博弈与业绩预期分化苑东生物近期股价波动加剧，短期异动主要受资金面与业绩预期博弈影响。2025年一季度归母净利润同比下滑19.2%，核心品种集采降价及股权激励费用计提加剧业绩兑现压力。创新转化与政策红利共振长期看，公司核心竞争力在于创新药研发与国际化布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095132a4689d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729095132a4689d68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","688513","BK0239"],"gpt_icon":0},{"id":"2554724705","title":"苑东生物(688513.SH)：培哚普利氨氯地平片(Ⅲ)获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2554724705","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554724705?lang=zh_cn&edition=full","pubTime":"2025-07-28 17:10","pubTimestamp":1753693812,"startTime":"0","endTime":"0","summary":"智通财经APP讯，苑东生物(688513.SH)发布公告，公司全资子公司成都硕德药业有限公司(以下简称“硕德药业”)于近日收到国家药品监督管理局(以下简称“国家药监局”)核准签发的《药品注册证书》，涉及药品：“培哚普利氨氯地平片(Ⅲ)”。培哚普利氨氯地平片(Ⅲ)为复方制剂，其主要成分为精氨酸培哚普利、苯磺酸氨氯地平，适应症为用于单药治疗不能充分控制高血压的成人患者;或者作为替代疗法适用于在相同剂量水平的培哚普利和氨氯地平联合治疗下病情得以控制的原发性高血压。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688513"],"gpt_icon":0},{"id":"2554716357","title":"华创医药投资观点&研究专题周周谈·第136期：高血压创新药是一笔好生意吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2554716357","media":"华创证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554716357?lang=zh_cn&edition=full","pubTime":"2025-07-26 00:00","pubTimestamp":1753459200,"startTime":"0","endTime":"0","summary":"本周行情回顾本周，中信医药指数上涨1.97%，跑赢沪深300指数0.28个百分点，在中信30个一级行业中排名第19位。本周涨幅前十名股票为海特生物、振东制药、塞力医疗、辰欣药业、仁度生物、康芝药业、易明医药、苑东生物、康泰医学、迈普医学。本周跌幅前十名股票*ST苏吴、永安药业、力生制药、首药控股-U、泽璟制药-U、科兴制药、信立泰、上海谊众、浙江震元、神州细胞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726164141a4647f7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726164141a4647f7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","688136","688513","159377","603367","688091","BK0239","688197","603716","688520","600200","688193","688266","399275"],"gpt_icon":0},{"id":"2554075750","title":"7月25日苑东生物涨6.53%，博时研究优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554075750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554075750?lang=zh_cn&edition=full","pubTime":"2025-07-25 16:27","pubTimestamp":1753432027,"startTime":"0","endTime":"0","summary":"证券之星消息，7月25日苑东生物涨6.53%创60日新高，收盘报55.61元，换手率3.84%，成交量6.78万手，成交额3.72亿元。重仓苑东生物的前十大公募基金请见下表：该股最近90天内共有8家机构给出评级，买入评级5家，增持评级3家。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共19家，其中持有数量最多的公募基金为博时基金的博时研究优选LOF。博时研究优选LOF目前规模为8.62亿元，最新净值0.8874，较上一交易日上涨2.46%，近一年上涨38.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072500026001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688513","160916","BK0239"],"gpt_icon":0},{"id":"2553226751","title":"单抗概念盘中拉升，百济神州-U涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553226751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553226751?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:39","pubTimestamp":1753234793,"startTime":"0","endTime":"0","summary":"07月23日，单抗概念盘中拉升，截至09点39分，单抗概念整体指数上涨0.66%，报2657.650点。从个股上来看，该概念的成分股中，百济神州-U涨0.48%，上海医药、国药一致、华海药业涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-1.40亿，其中苑东生物受到资金热捧，主力净流入348.54万；拉长时间线来看，该板块近20日主力资金净流入5384.79万。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093953954dd1c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723093953954dd1c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0201","BK0028","600521","BK0239","BK0185","688513","BK0188","688235","BK0070"],"gpt_icon":0},{"id":"2553625559","title":"苑东生物：股东拟询价转让336.95万股 占公司总股本的1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553625559","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553625559?lang=zh_cn&edition=full","pubTime":"2025-07-22 20:21","pubTimestamp":1753186877,"startTime":"0","endTime":"0","summary":"苑东生物公告，成都楠苑投资合伙企业（有限合伙）、成都竹苑投资合伙企业（有限合伙）、成都菊苑投资合伙企业（有限合伙）计划参与公司首发前股东询价转让，拟转让股份总数为336.95万股，占公司总股本的1.91%。本次询价转让为非公开转让，受让方通过询价转让受让的股份在受让后6个月内不得转让。受让方为具备相应定价能力和风险承受能力的机构投资者。转让原因为自身资金需求，价格下限不低于发送认购邀请书之日（2025年7月22日）前20个交易日股票交易均价的70%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/22202151897938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688513"],"gpt_icon":0},{"id":"2553283390","title":"单抗概念盘中拉升，百奥泰涨10.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553283390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553283390?lang=zh_cn&edition=full","pubTime":"2025-07-22 10:02","pubTimestamp":1753149767,"startTime":"0","endTime":"0","summary":"07月22日，单抗概念盘中拉升，截至10点02分，单抗概念整体指数上涨2.07%，报2720.500点。从个股上来看，该概念的成分股中，百奥泰涨10.17%，丽珠集团、苑东生物等5只股涨幅超过5%。从资金上来看，截止发稿，单抗概念概念主力净流入为2.39亿，其中恒瑞医药受到资金热捧，主力净流入6020.83万；拉长时间线来看，该板块近20日主力资金净流入6.67亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722100247a6b976c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722100247a6b976c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1328615791.USD","688513","688177","BK0188","LU2328871848.SGD","LU1064130708.USD","BK0028","LU0405327494.USD","LU1655091616.SGD","BK0239","BK0012","LU1997244956.HKD","LU2148510915.USD","LU2488822045.USD","BK0196","600276","LU0405327148.USD","BK0183","LU1997245094.SGD","LU1969619763.USD","LU2495084118.USD","LU1997245177.USD","BK0060","LU1064131003.USD"],"gpt_icon":0},{"id":"2552104655","title":"【重磅】苑东生物发威，首款抗肿瘤生物药1类新药来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2552104655","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552104655?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:04","pubTimestamp":1752739465,"startTime":"0","endTime":"0","summary":"精彩内容7月17日，成都苑东生物制药提交了注射用YLSH003的临床申请获得承办，该新药是公司首款抗肿瘤生物药1类新药。米内网数据显示，截至目前，#苑东生物已上市的抗肿瘤和免疫调节剂均为化学药，包括了乌苯美司胶囊、卡培他滨片、磷酸芦可替尼片、达可替尼片、阿昔替尼片、阿帕他胺片6个产品，暂无生物药获批。表1：苑东生物已获批临床的抗肿瘤和免疫调节新药情况来源：米内网数据库、公司年报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717160909a6af3cfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717160909a6af3cfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688513","BK0239","159839"],"gpt_icon":0},{"id":"2551817651","title":"麻醉药首仿只是“冰山一角”！起底苑东生物的超车密码","url":"https://stock-news.laohu8.com/highlight/detail?id=2551817651","media":"医药研究社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551817651?lang=zh_cn&edition=full","pubTime":"2025-07-14 20:39","pubTimestamp":1752496749,"startTime":"0","endTime":"0","summary":"据悉，近日苑东生物提交的4类仿制化药注射用磷丙泊酚二钠上市申请已获受理。多维布局下苑东生物蓄势爆发实际上，注射用磷丙泊酚二钠只是苑东生物新药布局的“冰山一角”。根据米内网数据，2024年至今，苑东生物已有十多个产品获批上市。财报显示，2025年第一季度，苑东生物实现营业总收入3.06亿元，同比下降2.97%；归母净利润6059.04万元，同比下降19.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714211031a44a1297&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714211031a44a1297&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688513","BK0239"],"gpt_icon":0},{"id":"2551184657","title":"苑东生物涨5.33% 创新驱动构建估值安全边际","url":"https://stock-news.laohu8.com/highlight/detail?id=2551184657","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551184657?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:30","pubTimestamp":1752474654,"startTime":"0","endTime":"0","summary":"苑东生物股价大幅上涨，最新价42.11元，涨跌幅为5.33%。估值压力亦不容忽视，截至7月9日动态市盈率31.83倍显著高于板块均值，半年报窗口期前部分资金选择兑现收益。创新驱动构建估值安全边际中长期看，苑东生物的核心竞争力在于创新药与国际化双轮驱动。公司研发投入强度连续三年超20%，经营性现金流同比增长18.6%，叠加2.63倍市净率低于创新药企均值，基本面为估值修复提供支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714143104a4491ef0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714143104a4491ef0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688513"],"gpt_icon":0},{"id":"2550652242","title":"苑东生物股价微跌0.79% 化学制药企业研发管线引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652242","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550652242?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:29","pubTimestamp":1751995758,"startTime":"0","endTime":"0","summary":"苑东生物7月8日股价报40.12元，较前一交易日下跌0.32元。当日成交量为15933手，成交金额达0.64亿元。苑东生物是一家专注于化学制药领域的创新型企业，主营业务涵盖创新药和高端仿制药的研发、生产和销售。公司产品管线涉及多个治疗领域，包括心血管系统、神经系统、抗肿瘤等。7月8日数据显示，苑东生物主力资金净流入187.54万元。公司当前总市值为70.82亿元，市盈率为29.22倍。风险提示：股市有风险，投资需谨慎。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709013704953b1c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709013704953b1c50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688513"],"gpt_icon":0},{"id":"2548514913","title":"苑东生物闪耀2025上海CPHI，共鉴制药创新力量","url":"https://stock-news.laohu8.com/highlight/detail?id=2548514913","media":"苑东生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548514913?lang=zh_cn&edition=full","pubTime":"2025-07-04 13:28","pubTimestamp":1751606889,"startTime":"0","endTime":"0","summary":"据统计，展会期间苑东生物累计接待来自40余个国家的200余家客户，达成超150场深度洽谈，客户对其新产品开发效率、项目进度管控及差异化产品线布局给予高度评价。面向未来，以创新驱动全球健康事业发展对于苑东生物而言，CPHI China 2025的圆满落幕并非终点，而是新征程的起点。未来，苑东生物将继续以开放姿态拥抱合作，用创新成果回应健康需求，以患者为中心，为全球医药产业发展贡献苑东力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704133018a4cebdff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704133018a4cebdff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688513","BK0239"],"gpt_icon":0},{"id":"2548088390","title":"苑东生物：公司未有数据管理人员口径人数统计","url":"https://stock-news.laohu8.com/highlight/detail?id=2548088390","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548088390?lang=zh_cn&edition=full","pubTime":"2025-07-01 18:30","pubTimestamp":1751365846,"startTime":"0","endTime":"0","summary":"证券之星消息，苑东生物(688513)07月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2024年底，贵公司拥有的数据管理人员数量是多少？苑东生物回复：尊敬的投资者，您好！公司高度重视推进数字化、智能化在制药产业中融合，数据管理人员分布于不同业务板块与部门发挥重要作用，目前未有“数据管理人员”口径的人数统计，公司的人员分类情况您可参见公司年度报告第四节中“员工情况”相关信息。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100030825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688513"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1754027345970,"stockEarnings":[{"period":"1week","weight":0.2318},{"period":"1month","weight":0.4754},{"period":"3month","weight":0.9114},{"period":"6month","weight":1.1234},{"period":"1year","weight":1.0898},{"period":"ytd","weight":1.1544}],"compareEarnings":[{"period":"1week","weight":-0.009},{"period":"1month","weight":0.0334},{"period":"3month","weight":0.0897},{"period":"6month","weight":0.0992},{"period":"1year","weight":0.2159},{"period":"ytd","weight":0.0661}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都苑东生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7091人(较上一季度增加10.71%)","perCapita":"24895股","listingDate":"2020-09-02","address":"四川省成都市郫都区高新区西源大道8号","registeredCapital":"17653万元","survey":"　　成都苑东生物制药股份有限公司的主营业务是化学原料药、高端化学药品及生物药品研发、生产、销售。公司的主要产品是高端化学药品、创新药、原料药。","listedPrice":44.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供苑东生物(688513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"苑东生物,688513,苑东生物股票,苑东生物股票老虎,苑东生物股票老虎国际,苑东生物行情,苑东生物股票行情,苑东生物股价,苑东生物股市,苑东生物股票价格,苑东生物股票交易,苑东生物股票购买,苑东生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"苑东生物(688513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供苑东生物(688513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}